Institutional investors hold a majority ownership of ANTH through the 56.67% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended September 2013, these large investors purchased a net $1.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GREAT POINT PARTNERS LLC Bought 1.0 Million shares of Anthera Pharmaceuticals I...
MOORE CAPITAL MANAGEMENT LP Bought 224.8 Thousand shares of Anthera Pharmaceuticals I...